Designation of substances as skin sensitizing chemicals: A commentary

Human and Experimental Toxicology

Volumn 22, Issue 8, 2003, Pages 439-443

  Kimber, Ian ^a   Dearman, R J ^a   Gerberick, G F ^b   Roggeband, R ^b   Basketter, D A ^c  

^a JEALOTT S HILL INTERNATIONAL RESEARCH CENTRE   (United Kingdom)

^b PROCTER AND GAMBLE COMPANY   (United States)

^c UNILEVER RESEARCH   (United Kingdom)

Author keywords

Allergic contact dermatitis; Classification; Predictive tests; Skin sensitization

Indexed keywords

CARCINOGEN; CHEMICAL COMPOUND; CONTACT ALLERGEN; OXAZOLONE;

ANALYTIC METHOD; ARTICLE; CHEMICAL ANALYSIS; CLASSIFICATION; CLINICAL OBSERVATION; HUMAN; MEDICAL RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SKIN SENSITIZATION; SKIN TEST; VALIDATION PROCESS; WORLD HEALTH ORGANIZATION;

ALLERGENS; ANIMALS; CLINICAL TRIALS; DERMATITIS, ALLERGIC CONTACT; HUMANS; MODELS, ANIMAL; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SKIN;

EID: 0041386213     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Schnuch A, Lessmann H, Schulz K-H, Becker D, Diepgen T, Drexler H, Erdmann S, Fartasch M, Greim H, Kricke-Helling P, Merget R, Merk H, Nowak D, Rothe A, Stropp G, Uter W, Wallenstein G. When should a substance be designated as sensitizing for the skin ('Sh') or for the airways ('Sa')? Hum Exp Toxicol 2002; 21: 439-44.
2. Knudsen BB, Wahlberg JE, Andersen I, Menne T. Classification of contact allergens. Proposal for criteria. Dermatosen 1993; 41: 5-9.
3. Gerberick GF, Ryan CA, Kimber I, Dearman RJ, Lea LJ, Basketter DA. Local lymph node assay: validation assessment for regulatory purposes. Am J Contact Derm 2000; 11: 3-18.
4. World Health Organization. Criteria for classification of skin- and airway sensitizing substances in the work and general environments. Flyvholm M-A, Andersen KE, Baranski B, Sarlo K eds. Denmark: WHO, 1997.
5. Basketter DA, Flyvholm MA, Menne T. Classification criteria for skin sensitizing chemicals: a commentary. Contact Derm 1999; 40: 175-82.
6. Kimber I, Basketter DA, Berthold K, Butler M, Garrigue J-U, Lea U, Newsome C, Roggeband R, Steiling W, Stropp G, Waterman S, Wiemann C. Skin sensitization testing in potency and risk assessment. Toxicol Sci 2001; 59: 198-208.
7. Kimber I, Dearman RJ, Basketter DA, Ryan CA, Gerberick GF. The local lymph node assay: past, present and future. Contact Derm 2002; 47: 315-28.
8. Kimber I, Pichowski JS, Basketter DA, Dearman RJ. Immune responses to contact allergens: novel approaches to hazard evaluation. Toxicol Lett 1999; 106: 237-46.
9. Kimber I, Pichowski JS, Betts CJ, Cumberbatch M, Basketter DA, Dearman RJ. Alternative approaches to the identification and characterization of chemical allergens. Toxic in vitro 2001; 15: 307-12.
10. Ryan CA, Hulette BC, Gerberick GF. Approaches for the development of cell-based in vitro methods for contact sensitization. Toxic in vitro 2001; 15: 43-55.
11. Barratt MD, Basketter DA, Roberts DW. Quantitative structure activity relationships. In Lepoittevin J-P, Basketter DA, Dooms-Goosens A, Karlberg A-T eds. The molecular basis of allergic contact dermatitis. Heidelberg: Springer-Verlag, 1997: 129-54.
12. Smith CK, Hotchkiss SAM. Allergic contact dermatitis: chemical and metabolic mechanisms. London: Taylor & Francis, 2001.
13. Kimber I, Basketter DA. Contact sensitization: a new approach to risk assessment. Human Ecol Risk Assess 1997; 3: 385-95.
14. Basketter DA, Gerberick GF, Kimber I. Measurement of allergenic potency using the local lymph node assay. Trends Pharmacol Sci 2001; 22: 254-65.
15. Basketter DA, Blaikie L, Dearman RJ, Kimber I, Ryan CA, Gerberick GF, Harvey P, Evans P, White IR, Rycroft RJG. Use of the local lymph node assay for the estimation of relative contact allergenic potency. Contact Derm 2000; 42: 344-48.
16. Gerberick GF, Robinson MK, Ryan CA, Dearman RJ, Kimber I, Basketter DA, Wright Z, Marks JG. Contact allergenic potency: correlation of human and local lymph node assay data. Am J Contact Derm 2001; 12: 156-61.